glp-1 agonist pharmacology Glucagon-like peptide-1 GLP-1 Agonists are commonly used

DPP4 can cleave various peptides, leading to inactivation and/or generation of new bioactive peptides

Cell 185 , 24782494.e2428 (2022)

Depletion of CD25-specific antibodies in Treg leads to a decrease in the number of NPCs after experimental stroke (77)

Unlike injectable GLP-1s, orforglipron is a once-daily oral agent, offering an alternative for patients averse to injections

Moreover, in the SPP/PS1 transgenic AD mouse model, therapy with DA5-CH improved the memory function of AD animals and decreased the levels of amyloid senile plaques and phosphorylated tau protein in the hippocampus [57]

Obesity and meningioma: a US population-based study paired with analysis of a multi-institutional cohort